Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics

Current Opinion in Pediatrics

Volumn 22, Issue 5, 2010, Pages 561-566

  Linask, Kersti K ^a   Huhta, James ^a,b,c,d  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

alcohol; birth defects; folate; inositol; Wnt b catenin

Indexed keywords

ALCOHOL; BETA CATENIN; FOLIC ACID; HOMOCYSTEINE; INOSITOL; LITHIUM; WNT PROTEIN;

BIRTH DEFECT; CONGENITAL HEART MALFORMATION; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC REGULATION; HEART DEVELOPMENT; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VITAMIN SUPPLEMENTATION;

ANIMALS; BETA CATENIN; EPIGENESIS, GENETIC; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MATERNAL EXPOSURE; PREGNANCY; SIGNAL TRANSDUCTION; VITAMIN B COMPLEX;

EID: 77957562739     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32833e2723     Document Type: Review

References (75)

1. Srivastava D. Genetic regulation of cardiogenesis and congenital heart disease. Annu Rev Pathol 2006;1:199-213.
2. Lupo PJ, Goldmuntz E, Mitchell LE. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotechnol 2010;2010:630940.
3. Green A. Outcomes of congenital heart disease: a review. Pediatr Nurs 2004;30:280-284.
4. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge - a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young - endorsed by the American Academy of Pediatrics. Circulation 2007;115:2995-3014.
5. Yonkers KA, Stowe Z, Leibenluft E, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004;161:608-620.
6. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006;126:1037-1048.
7. de la Cruz MV, Sanchez Gomez C, Cayre R. The developmental components of the ventricles: their significance in congenital cardiac malformations. Cardiol Young 1991;1:123-128. In this study, for the first time, the existence of a second (anterior) heart field is described.
8. Markwald RR, Trusk R, Moreno-Rodriguez R. Formation and septation of the tubular heart: integrating the dynamics of morphology with emerging molecular concepts. In: de la Cruz MV, Markwald RR, editors. Living morphogenesis of the heart. Boston: Birkhauser; 1998. pp. 43-84.
9. Verzi MP, McCulley DJ, De Val S, et al. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. Dev Biol 2005;287:134-145. This study is a cell lineage analysis of derivatives of the second heart field.
10. Linask KK, Vanauker M. A role for the cytoskeleton in heart looping. ScientificWorldJournal 2007;7:280-298.
11. Linask KK. Regulation of heart morphology: current molecular and cellular perspectives on the coordinated emergence of cardiac form and function. Birth Defects Res C Embryo Today 2003;69:14-24.
12. Beksac MS, Balci S, Guvendag Guven ES, et al. Complex conotruncal cardiac anomalies consecutively in three siblings from a consanguineous family possibly associated with maternal hyperhomocysteinemia. Arch Gynecol Obstet 2007;276:547-549.
13. Brown AS, Bottiglieri T, Schaefer CA, et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 2007;64:31-39.
14. Galdieri LC, Arrieta SR, Silva CM, et al. Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Arch Med Res 2007;38:212-218.
15. Pickell L, Li D, Brown K, et al. Methylenetetrahydrofolate reductase deficiency and low dietary folate increase embryonic delay and placental abnormalities in mice. Birth Defects Res A Clin Mol Teratol 2009;85:531-541.
16. Verkleij-Hagoort A, Bliek J, Sayed-Tabatabaei F, et al. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 2007;143:952-960.
17. Chen J, Han M, Manisastry SM, et al. Molecular effects of lithium exposure during mouse and chick gastrulation and subsequent valve dysmorphogenesis. Birth Defects Res A Clin Mol Teratol 2008;82:508-518. This study shows that one-time lithium exposure during gastrulation leads to cardiac, including valve, defects over a week later after exposure in the mouse embryo.
18. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 2008;13:285-292.
19. Bailey B, Sokol R. Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol 2008;51:436-444.
20. Burd L, Klug MG, Bueling R, et al. Mortality rates in subjects with fetal alcohol spectrum disorders and their siblings. Birth Defects Res A Clin Mol Teratol 2008;82:217-223.
21. Carmichael SL, Shaw GM, Yang W, Lammer EJ. Maternal periconceptional alcohol consumption and risk for conotruncal heart defects. Birth Defects Res A Clin Mol Teratol 2003;67:875-878.
22. Datta S, Turner D, Singh R, et al. Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid. Birth Defects Res A Clin Mol Teratol 2008;82:177-186.
23. Giles S, Boehm P, Brogan C, Bannigan J. The effects of ethanol on CNS development in the chick embryo. Reprod Toxicol 2008;25:224-230.
24. Grewal J, Carmichael SL, Ma C, et al. Maternal periconceptional smoking and alcohol consumption and riskfor select congenital anomalies. Birth Defects Res A Clin Mol Teratol 2008;82:519-526.
25. Sokol R, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003;290:2996-2999.
26. Han M, Serrano MC, Lastra-Vicente R, et al. Folate rescues lithium-, homo-cysteine-and Wnt3A-induced vertebrate cardiac anomalies. Dis Model Mech 2009;2:467-478. In this study, folic acid is demonstrated to protect the vertebrate embryo from the effects of the drug lithium, HCy or Wnt3A exposure.
27. Manisastry SM, Han M, Linask KK. Early temporal-specific responses and differential sensitivity to lithium and Wnt-3A exposure during heart development. Dev Dyn 2006;235:2160-2174.
28. Serrano M, Han M, Brinez P, Linask K. Fetal alcohol syndrome: cardiac birth defects in mice and prevention with folate. Am J Obstet Gynecol 2010;203:75e7-75e15. This study shows that folic acid protection of cardiac defects is extended to fetal alcohol syndrome.
29. Cains S, Shepherd A, Nabiuni M, et al. Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus. J Neuropathol Exp Neurol 2009;68:404-416.
30. McNeil CJ, Hay SM, Rucklidge GJ, et al. Maternal diets deficient in folic acid and related methyl donors modify mechanisms associated with lipid metabolism in the fetal liver of the rat. Br J Nutr 2009;102:1445-1452.
31. Zeisel SH. Importance of methyl donors during reproduction. Am J Clin Nutr 2009;89:673S-677S.
32. Kwon C, Arnold J, Hsiao EC, et al. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA 2007;104:10894-10899.
33. Ueno S, Weidinger G, Osugi T, et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007;104:9685-9690. In this study, a biphasic role for canonical Wnt is shown in heart development.
34. Yamaguchi TP. Heads or tails: Wnts and anterior-posterior patterning. Curr Biol 2001;11: R713-R724.
35. Gammill LS, Bronner-Fraser M. Genomic analysis of neural crest induction. Development 2002;129:5731-5741.
36. Gammill LS, Bronner-Fraser M. Neural crest specification: migrating into genomics. Nat Rev Neurosci 2003;4:795-805.
37. Knecht AK, Bronner-Fraser M. Induction of the neural crest: a multigene process. Nat Rev Genet 2002;3:453-461.
38. Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007;13:4042-4045.
39. Paige SL, Osugi T, Afanasiev OK, et al. Endogenous Wnt/beta-catenin signaling is required for cardiac differentation in human embryonic stem cells. PLoS One 2010;5: e11134.
40. Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 2010;106:1798-1806.
41. Willert K, Jones K. Wnt signaling: is the party in the nucleus? Genes Dev 2006;20:1394-1404.
42. Kutateladze T. Translation of the phosphoinositide code by PI effectors. Nat Chem Biol 2010;6:507-513.
43. Qin Y, Lin L, Pan W, Wu D. Regulation of phosphatidylinositol kinases and metabolism by Wnt3A and Dvl. J Biol Chem 2009;284:22544-22548. This study shows that canonical Wnt signaling is linked to phosphatidylinositol signaling.
44. Linask KK, Knudsen KA, Gui YH. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol 1997;185:148-164.
45. Linask KK. N-cadherin localization in early heart development and polar expression of Na, K-ATPase, and integrin during pericardial coelom formation and epithelialization of the differentiating myocardium. Dev Biol 1992;151:213-224.
46. Lin LZ, Cui L, Zhou W, et al. Beta-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis. Proc Natl Acad Sci USA 2007;104:931 3-9318.
47. Cai CL, Liang X, Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003;5:877-889.
48. Foley AC, Mercola M. Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev 2005;19:387-396.
49. Marvin MJ, Di Rocco G, Gardiner A, et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001;15:316-327.
50. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93:8455-8459.
51. Gundogan F, Elwood G, Longato L, et al. Impaired placentation in fetal alcohol syndrome. Placenta 2008;29:148-157.
52. Makedos G, Papanicolaou A, Hitoglou A, et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Arch Gynecol Obstet 2007;275:121-124.
53. Pollheimer J, Loregger T, Sonderegger S, et al. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 2006;168:1134-1147.
54. Czeizel A. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-183.
55. Czeizel A. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998;78:151-161.
56. Ionescu-Ittu R, Marelli A, Mackie A, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 2009;338: b1673. This study shows that folic acid is associated with protection from severe cardiac defects in the human population.
57. Deranieh R, Greenberg M. Cellular consequences of inositol depletion. Biochem Soc Trans 2009;37:1099-1103.
58. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996;6:1664-1668.
59. Bar-Oz B, Koren G, Nguyen P, Kapur BM. Folate fortification and supplementation: are we there yet? Reprod Toxicol 2008;25:408-412.
60. Nguyen P, Tam C, O'Connor DL, et al. Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age. Am J Clin Nutr 2009;89:844-852.
61. Greene ND, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 1997;3:60-66.
62. Reece E, Khandelwal M, Wu Y, Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 1997;176:536-539.
63. Jesch S, Zhao X, Wells M, Henry S. Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. J Biol Chem 2005;280:9106-9118.
64. Aguilera O, Fernandez AF, Munoz A, Fraga MF. Epigenetics and environment: a complex relationship. J Appl Physiol 2010;109:243-251.
65. Bollati V, Baccarelli A. Environmental epigenetics. Heredity 2010;105:105-112.
66. Kiefer J. Epigenetics in development. Dev Dyn 2007;236:1144-1156.
67. Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 2005;19:563-573.
68. Sierra J, Yoshida T, Joazeiro CA, Jones KA. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 2006;20:586-600.
69. Liu Y, Balaraman Y, Wang G, et al. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 2009;4:500-511.
70. Ouko L, Shantikumar K, Knezovich S, et al. Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2009;33:1615-1627.
71. Chi P, Allis CD, Wang GG. Covalent histone modifications: miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010;10:457-469.
72. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2010. [Epub ahead of print]
73. Villeneuve L, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010;299: F14-25.
74. Aagaard-Tillery KM, Grove K, Bishop J, et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 2008;41:91-102.
75. Ptak C, Petronis A. Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci 2010;12:25-35.